At the molecular level, it was found that HK2 alteration drove metabolic reprogramming toward OxPhos and modulated oncogenic Akt and mutant TP53-mediated signals in HNSCC cells. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.